StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)

Close on Nov 17, 2026Market cap $5.68MP/E –Yield –

Biomerica cash

Cash and short-term investments held at the end of each period.

Biomerica's cash was $2.73M at Aug 31, 2026. For fiscal 2026 it was $1.31M, down 45.5% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $9.72M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2026May 31, 2026$1.31M-45.5%
FY2025May 31, 2025$2.40M-42.5%
FY2024May 31, 2024$4.17M-57.1%
FY2023May 31, 2023$9.72M+64.3%
FY2022May 31, 2022$5.92M+40.9%
FY2021May 31, 2021$4.20M-51.4%
FY2020May 31, 2020$8.64M+1158.2%
FY2019May 31, 2019$686.79K-43.0%
FY2018May 31, 2018$1.20M-1.7%
FY2017May 31, 2017$1.23M-35.1%
FY2016May 31, 2016$1.89M+73.6%
FY2015May 31, 2015$1.09M-27.9%
FY2014May 31, 2014$1.51M-38.9%
FY2013May 31, 2013$2.47M+129.2%
FY2012May 31, 2012$1.08M+8.9%
FY2011May 31, 2011$989.27K-6.2%
FY2010May 31, 2010$1.06M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$2.73M-10.5%
Q4 FY2026CQ2 2026May 31, 2026$1.31M-45.5%
Q3 FY2026CQ1 2026Feb 28, 2026$1.34M-56.3%
Q2 FY2026CQ4 2025Nov 30, 2025$2.54M+7.2%
Q1 FY2026CQ3 2025Aug 31, 2025$3.05M+8.3%
Q4 FY2025CQ2 2025May 31, 2025$2.40M-42.5%
Q3 FY2025CQ1 2025Feb 28, 2025$3.06M-42.5%
Q2 FY2025CQ4 2024Nov 30, 2024$2.37M-66.8%
Q1 FY2025CQ3 2024Aug 31, 2024$2.82M-64.7%
Q4 FY2024CQ2 2024May 31, 2024$4.17M-57.1%
Q3 FY2024CQ1 2024Feb 29, 2024$5.32M+59.0%
Q2 FY2024CQ4 2023Nov 30, 2023$7.13M+40.8%
Q1 FY2024CQ3 2023Aug 31, 2023$7.99M+31.5%
Q4 FY2023CQ2 2023May 31, 2023$9.72M+64.3%
Q3 FY2023CQ1 2023Feb 28, 2023$3.35M-67.1%
Q2 FY2023CQ4 2022Nov 30, 2022$5.07M-29.6%
Q1 FY2023CQ3 2022Aug 31, 2022$6.08M+21.6%
Q4 FY2022CQ2 2022May 31, 2022$5.92M+40.9%
Q3 FY2022CQ1 2022Feb 28, 2022$10.17M+93.0%
Q2 FY2022CQ4 2021Nov 30, 2021$7.20M+26.7%
Q1 FY2022CQ3 2021Aug 31, 2021$5.00M-28.3%
Q4 FY2021CQ2 2021May 31, 2021$4.20M-51.4%
Q3 FY2021CQ1 2021Feb 28, 2021$5.27M+120.4%
Q2 FY2021CQ4 2020Nov 30, 2020$5.68M+567.9%
Q1 FY2021CQ3 2020Aug 31, 2020$6.96M+762.4%
Q4 FY2020CQ2 2020May 31, 2020$8.64M+1158.2%
Q3 FY2020CQ1 2020Feb 29, 2020$2.39M+160.6%
Q2 FY2020CQ4 2019Nov 30, 2019$850.99K-24.4%
Q1 FY2020CQ3 2019Aug 31, 2019$807.55K+38.4%
Q4 FY2019CQ2 2019May 31, 2019$686.79K-43.0%
Q3 FY2019CQ1 2019Feb 28, 2019$917.94K+53.8%
Q2 FY2019CQ4 2018Nov 30, 2018$1.12M+37.6%
Q1 FY2019CQ3 2018Aug 31, 2018$583.69K-46.0%
Q4 FY2018CQ2 2018May 31, 2018$1.20M-1.7%
Q3 FY2018CQ1 2018Feb 28, 2018$597.03K-61.3%
Q2 FY2018CQ4 2017Nov 30, 2017$817.81K-49.2%
Q1 FY2018CQ3 2017Aug 31, 2017$1.08M–
Q4 FY2017CQ2 2017May 31, 2017$1.23M–
Q3 FY2017CQ1 2017Feb 28, 2017$1.54M–
Q2 FY2017CQ4 2016Nov 30, 2016$1.61M–

More Biomerica figures

See a number that looks wrong?